You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis: The ACCESS Randomized Trial
|
|---|---|
| Published in |
JAMA: Journal of the American Medical Association, March 2013
|
| DOI | 10.1001/jama.2013.2194 |
| Pubmed ID | |
| Authors |
Steven M. Opal, Pierre-Francois Laterre, Bruno Francois, Steven P. LaRosa, Derek C. Angus, Jean-Paul Mira, Xavier Wittebole, Thierry Dugernier, Dominique Perrotin, Mark Tidswell, Luis Jauregui, Kenneth Krell, Jan Pachl, Takeshi Takahashi, Claus Peckelsen, Edward Cordasco, Chia-Sheng Chang, Sandra Oeyen, Naoki Aikawa, Tatsuya Maruyama, Roland Schein, Andre C. Kalil, Marc Van Nuffelen, Melvyn Lynn, Daniel P. Rossignol, Jagadish Gogate, Mary B. Roberts, Janice L. Wheeler, Jean-Louis Vincent, for the ACCESS Study Group |
| Abstract |
Eritoran is a synthetic lipid A antagonist that blocks lipopolysaccharide (LPS) from binding at the cell surface MD2-TLR4 receptor. LPS is a major component of the outer membrane of gram-negative bacteria and is a potent activator of the acute inflammatory response. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 14% |
| United States | 1 | 14% |
| Unknown | 5 | 71% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 57% |
| Practitioners (doctors, other healthcare professionals) | 2 | 29% |
| Scientists | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 372 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 3 | <1% |
| Canada | 3 | <1% |
| Australia | 1 | <1% |
| Brazil | 1 | <1% |
| United Kingdom | 1 | <1% |
| Denmark | 1 | <1% |
| Spain | 1 | <1% |
| Japan | 1 | <1% |
| Unknown | 360 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 61 | 16% |
| Researcher | 59 | 16% |
| Student > Bachelor | 43 | 12% |
| Student > Master | 39 | 10% |
| Other | 29 | 8% |
| Other | 69 | 19% |
| Unknown | 72 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 138 | 37% |
| Biochemistry, Genetics and Molecular Biology | 37 | 10% |
| Agricultural and Biological Sciences | 33 | 9% |
| Immunology and Microbiology | 30 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 4% |
| Other | 36 | 10% |
| Unknown | 82 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 48. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2024.
All research outputs
#896,774
of 25,800,372 outputs
Outputs from JAMA: Journal of the American Medical Association
#7,883
of 36,827 outputs
Outputs of similar age
#6,207
of 211,386 outputs
Outputs of similar age from JAMA: Journal of the American Medical Association
#56
of 233 outputs
Altmetric has tracked 25,800,372 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 36,827 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 72.7. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 211,386 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 233 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.